DIA
AXSM icon

Dana Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History

Dana Investment Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.59M Sell
22,850
-3,529
-13% -$765K 0.15% 180
2026
Q1 		$4.46M Sell
26,379
-6,818
-21% -$1.18M 0.13% 189
2025
Q4 		$6.06M Sell
33,197
-415
-1% -$57.9K 0.18% 137
2025
Q3 		$4.08M Buy
33,612
+9,539
+40% +$1.07M 0.12% 195
2025
Q2 		$2.51M Buy
24,073
+12,760
+113% +$1.35M 0.08% 251
2025
Q1 		$1.32M Sell
11,313
-5,081
-31% -$579K 0.05% 341
2024
Q4 		$1.39M Sell
16,394
-1,183
-7% -$109K 0.05% 347
2024
Q3 		$1.58M Sell
17,577
-2,147
-11% -$187K 0.05% 325
2024
Q2 		$1.59M Buy
19,724
+697
+4% +$51.6K 0.05% 324
2024
Q1 		$1.52M Buy
19,027
+5,386
+39% +$452K 0.05% 330
2023
Q4 		$1.09M Sell
13,641
-507
-4% -$33.9K 0.05% 242
2023
Q3 		$989K Sell
14,148
-3,468
-20% -$259K 0.05% 232
2023
Q2 		$1.27M Sell
17,616
-1,230
-7% -$90.7K 0.06% 219
2023
Q1 		$1.16M Sell
18,846
-80
-0.4% -$5.26K 0.06% 217
2022
Q4 		$1.46M Buy
18,926
+4,061
+27% +$243K 0.08% 181
2022
Q3 		$663K Sell
14,865
-2,609
-15% -$130K 0.04% 269
2022
Q2 		$669K Buy
17,474
+1,468
+9% +$46.4K 0.03% 279
2022
Q1 		$662K Sell
16,006
-3,613
-18% -$112K 0.03% 248
2021
Q4 		$741K Sell
19,619
-10,756
-35% -$396K 0.03% 236
2021
Q3 		$1M Buy
30,375
+10,527
+53% +$410K 0.05% 204
2021
Q2 		$1.34M Buy
19,848
+1,506
+8% +$90.4K 0.06% 194
2021
Q1 		$1.04M Buy
+18,342
New +$1.29M 0.05% 209

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dana Investment Advisors's AXSM Position: Q2 2026 in Review

Dana Investment Advisors reduced its Axsome Therapeutics (AXSM) stake by 13% in Q2 2026, selling an estimated $765K and leaving 22,850 shares worth $5.59M. The position accounts for 0.15% of the portfolio, ranked #180.

Dana Investment Advisors first reported a position in AXSM in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.06M in Q4 2025. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Dana Investment Advisors held 22,850 shares of Axsome Therapeutics worth $5.59M as of Q2 2026.
  • Dana Investment Advisors sold 3,529 Axsome Therapeutics shares in Q2 2026, an estimated $765K.
  • Axsome Therapeutics made up 0.15% of Dana Investment Advisors's portfolio in Q2 2026, its #180 holding.
  • Dana Investment Advisors first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 22 quarters since.
  • Dana Investment Advisors's Axsome Therapeutics position peaked at $6.06M in Q4 2025.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.